Condition

Hepatitis C Infection (2)

HIV Infection (1)

Overall Status

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

AIDS Clinical Trials Group (1)

Bristol-Myers Squibb (1)

Collaborator

AbbVie (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Intervention

daclatasvir (1)

glecaprevir/pibrentasvir (g/p) (1)

peginterferon alpha-2a (1)

placebo (1)

ribavirin (1)

ribavirin (rbv) (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

Hepatitis C Infection

Showing NaN - NaN of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Hepatitis C Infection, HIV Infection Trial in Brazil, Puerto Rico, United States (Glecaprevir/Pibrentasvir (G/P), Ribavirin

Recruiting

Hepatitis C Infection
HIV Infection

Glecaprevir/Pibrentasvir (G/P)
Ribavirin (RBV)

San Diego, California
+15 more

Dec 19, 2022

Hepatitis C Infection Trial in France, United States (Daclatasvir, Placebo, Peginterferon alpha-2a)

Completed

Hepatitis C Infection

Daclatasvir
+3 more

Montgomery, Alabama
+13 more

Sep 23, 2015